Access of the novel biferrocene amino acid 7 is provided by two different routes, namely, via desymmetrization of a biferrocene and via palladium-catalyzed cross-coupling of two substituted ferrocenes. The dissymmetric biferrocene 7 is head−head coupled to ureylene-bridged bis(biferrocene) 9 and also head−tail coupled to amide-bridged bis(biferrocene) 14. The monomer 7 and the dimers 9 and 14 are oxidized to mixed-valent cations 7+, 9+, 92+, and 142+. The valencies are trapped in the solid state as shown by Mössbauer and EPR spectroscopy and by X-ray diffraction analysis of [7](I3). Paramagnetic NMR shift studies (7 → 7+) suggest that the hole is localized at the N-substituted ferrocene unit [BocNH-{III}-{II}-COOMe]+. According to DFT calculations and individual redox potentials, the dications 92+ and 142+ are best described as [MeOOC-{II}-{III}-NHCONH-{III}-{II}-COOMe]2+ and [BocNH-{III}-{II}-CONH-{III}-{II}-COOMe]2+ valence isomers, respectively. The interaction between neighboring ferrocene/ferrocenium sites in the mixed-valent systems is determined by Hush analyses of the NIR intervalence bands. The extent depends on the bridge type (direct link, amide, ureylene) and the zero-point difference of the individual redox-active units.
No takes yet. Share an insight, caveat, or question.
Siebler et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: